Conference Presentation

Reproductive Considerations for Women with the Fragile X Premutation

01 h 00 m

Dr. Heather Hipp, a reproductive endocrinologist at Emory University, discusses reproductive considerations for women with a Fragile X premutation, including FXPOI and the process for diagnosis.

About the Webinar

Having the premutation typically means a diminished ovarian reserve and early menopause at an average age of 46 vs. 51 for the general population. Dr. Hipp also discusses FXPOI, which appears in 20% of women with the premutation. To make a diagnosis, the woman should be younger than 40 and experiencing absent or irregular cycles, and will need menopausal hormone labs. Learn more about:

About the Presenter

Heather Hipp

Heather Hipp

Emory University School of Medicine, Georgia
Associate Professor

Heather Hipp, MD, is an associate professor at the Emory University School of Medicine and works at the Emory Reproductive Center caring for patients with reproductive endocrine disorders and infertility.

Dr. Hipp helped author the recent Fragile X Clinical & Research Consortium guidelines for FXPOI (Fragile X-associated primary ovarian insufficiency). Dr. Hipp is board certified in obstetrics and gynecology (OB-GYN) and reproductive endocrinology and infertility (REI). She maintains a special clinical interest in women with primary ovarian insufficiency (POI), working to care for their overall health and reproductive needs. She currently serves as the subspecialty resident educator for the REI rotation, is the program director for the REI fellowship, and is the director for the Emory Egg Bank. Dr. Hipp is also an advisor in the NFXF’s Research Readiness Program.

Dr. Hipp graduated from Duke University with double majors in biology and English and then matriculated at Emory University for her doctorate and graduated cum laude. She stayed at Emory for her residency in gynecology and obstetrics, where she served as administrative chief resident for her final year and her fellowship in reproductive endocrinology and infertility. During her fellowship in REI, she worked with Emory’s National Fragile X Center on ongoing analysis of genetic modifiers of POI in women with the Fragile X premutation.